Masong, Harlene .
HRN: 27-69-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness
09/02/2025
CEFUROXIME 500MG (TAB)
09/02/2025
09/09/2025
PO
1 TAB
Q12H
S/P NSVD
Checking Initial Appropriateness